SCHEMBL24543109

SCHEMBL24543109

CCOc1ccc(-c2ccc(NC(=O)C(C)(C)Oc3ccc(F)cc3)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARA Q07869 2/20 0.54
▸ ALDH1A1 P00352 2/20 0.53
▸ ADORA2A P29274 1/20 0.52
▸ ADORA2B P29275 1/20 0.52
▸ L3MBTL1 Q9Y468 1/20 0.52
▸ MEN1 O00255 2/20 0.50
▸ LMNA P02545 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ CYP1A2 P05177 2/20 0.50
▸ FAAH O00519 2/20 0.50
▸ POLB P06746 2/20 0.50
▸ TDP1 Q9NUW8 1/20 0.50
▸ PAX8 Q06710 1/20 0.47
▸ CYP2C9 P11712 2/20 0.47
▸ CYP2C19 P33261 2/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ GAA P10253 1/20 0.46
▸ CHRNA7 P36544 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24542771 0.89 ADORA2A (0.48) PPARAALDH1A1ADORA2AADORA2BL3MBTL1
SCHEMBL24542769 0.88 ADORA2A (0.47) PPARAALDH1A1ADORA2AADORA2BL3MBTL1
SCHEMBL30901940 0.88 ADORA2A (0.47) PPARAALDH1A1ADORA2AADORA2BL3MBTL1
SCHEMBL24542732 0.87 EPHX2 (0.56) PPARAALDH1A1ADORA2AADORA2BL3MBTL1
SCHEMBL24542722 0.86 PPARA (0.50) PPARAALDH1A1ADORA2AADORA2BL3MBTL1
SCHEMBL24542730 0.86 PDK1 (0.55) PPARAALDH1A1ADORA2AADORA2BMEN1
SCHEMBL24542725 0.85 PPARA (0.57) PPARAALDH1A1ADORA2AADORA2BLMNA
SCHEMBL24543063 0.84 PPARA (0.54) PPARAALDH1A1L3MBTL1MEN1LMNA
SCHEMBL24542766 0.84 TRPV1 (0.54) PPARAADORA2AADORA2BMEN1LMNA
SCHEMBL24543202 0.83 EPHX2 (0.60) FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4263492-B1 MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88 ACADIA PHARM INC (US) 2025-04-09 — — EP disclosed
US-20240132450-A1 MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88 ACADIA PHARMACEUTICALS INC. 2024-04-25 — — US disclosed
EP-4263492-A1 MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88 ACADIA Pharmaceuticals Inc. (US) 2023-10-25 — — EP disclosed
WO-2022129933-A1 MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88 Pandeia Therapeutics Limited (GB) 2022-06-23 — — WO disclosed
WO-2022129933-A1 MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88 Pandeia Therapeutics Limited (GB) 2022-06-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240132450-A1 MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88 GPR88, GPR65, GPR68 PPARA 355/4885ALDH1A1 2127/4885ADORA2A 175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback